Scholarlink

Background <p>Diabetic nephropathy (DN) remains a leading cause of end-stage kidney disease despite current therapies. Experimental data implicate Toll-like receptor 4 (TLR4) in DN pathogenesis; however, human evidence, particularly on histological severity and long-term outcomes, is limited. We hypothesized that renal TLR4 expression is correlated with tissue injury and adverse prognosis in DN.</p> Methods <p>In 146 adults with biopsy-confirmed DN, we evaluated TLR4 expression in the glomeruli and proximal tubules using immunohistochemical staining. Histological injuries were scored according to the Renal Pathology Society classification. TLR4 expression was graded in the proximal tubular and glomerular epithelial cells. We subsequently investigated whether TLR4 expression is associated with kidney histological damage and whether it relates to renal prognosis.</p> Results <p>There was a significant difference in the severity of glomerular lesions across different levels of glomerular epithelial TLR4 expression. Additionally, the extent of interstitial fibrosis and tubular atrophy (IFTA) and interstitial inflammation significantly differed across different levels of proximal tubular TLR4 expression. Overall, TLR4 status did not predict kidney failure-free survival; however, among patients with IFTA &lt; 50% (n = 63), moderate-to-severe tubular TLR4 expression was associated with worse survival than negative-to-mild expression (<i>p</i> = 0.021). In the low-IFTA subgroup, there were significant differences in systolic blood pressure, proteinuria, and total cholesterol levels across the levels of tubular TLR4 expression.</p> Conclusion <p>These findings indicate possible involvement of TLR4 expression in histological injury and poor renal prognosis in DN, especially before the development of extensive fibrosis. TLR4 and its endogenous ligands are potential novel therapeutic targets for DN.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Progression of diabetic nephropathy and adverse renal outcomes: possible involvement of Toll-like receptor 4 expression

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月24日

查看全文
  • Ayano Saito,
  • Fumito Abe,
  • Masaya Saito,
  • Mako Hashimoto,
  • Tatsuro Kanazawa,
  • Takuya Kumagai,
  • Mai Sakaguchi,
  • Futaba Ishii,
  • Takahiro Nakayama,
  • Hideki Wakui,
  • Naoto Takahashi

摘要

Background

Diabetic nephropathy (DN) remains a leading cause of end-stage kidney disease despite current therapies. Experimental data implicate Toll-like receptor 4 (TLR4) in DN pathogenesis; however, human evidence, particularly on histological severity and long-term outcomes, is limited. We hypothesized that renal TLR4 expression is correlated with tissue injury and adverse prognosis in DN.

Methods

In 146 adults with biopsy-confirmed DN, we evaluated TLR4 expression in the glomeruli and proximal tubules using immunohistochemical staining. Histological injuries were scored according to the Renal Pathology Society classification. TLR4 expression was graded in the proximal tubular and glomerular epithelial cells. We subsequently investigated whether TLR4 expression is associated with kidney histological damage and whether it relates to renal prognosis.

Results

There was a significant difference in the severity of glomerular lesions across different levels of glomerular epithelial TLR4 expression. Additionally, the extent of interstitial fibrosis and tubular atrophy (IFTA) and interstitial inflammation significantly differed across different levels of proximal tubular TLR4 expression. Overall, TLR4 status did not predict kidney failure-free survival; however, among patients with IFTA < 50% (n = 63), moderate-to-severe tubular TLR4 expression was associated with worse survival than negative-to-mild expression (p = 0.021). In the low-IFTA subgroup, there were significant differences in systolic blood pressure, proteinuria, and total cholesterol levels across the levels of tubular TLR4 expression.

Conclusion

These findings indicate possible involvement of TLR4 expression in histological injury and poor renal prognosis in DN, especially before the development of extensive fibrosis. TLR4 and its endogenous ligands are potential novel therapeutic targets for DN.